Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.48
Delayed Data
As of 4:00pm ET
 +0.02 / +0.81%
Today’s Change
1.51
Today|||52-Week Range
10.22
+21.57%
Year-to-Date

Today’s Trading

Previous close2.46
Today’s open2.49
Day’s range2.42 - 2.53
Volume1,207,912
Average volume (3 months)1,792,596
Market cap$214.8M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...-0.15-3.19%
RXDXIgnyta Inc-0.05-1.00%
KDMNKadmon Holdings Inc-0.08-1.62%
CYADCelyad SA-1.51-6.29%
Data as of 4:03pm ET, 01/19/2017

Financials

Last reporting date--
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs